Search

You searched for "examination"

2922 results found

An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection

1 December 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....

Newmedica Plymouth - Intraocular lens choice: weighing up the options

15 July 2025
This interactive workshop will explore the advantages and disadvantages of different types of modern intraocular lenses. By considering patient lifestyle factors, personality traits, and prescriptions, the session will help you reflect on scenarios designed to enhance your knowledge of intraocular...

Newmedica Birmingham - Intraocular lens choice: weighing up the options

1 July 2025 -7 July 2025
This interactive workshop will explore the advantages and disadvantages of different types of modern intraocular lenses. By considering patient lifestyle factors, personality traits, and prescriptions, the session will help you reflect on scenarios designed to enhance your knowledge of intraocular...

Management of DMO and PDR in 2019

10 October 2019 | | EYE - Vitreo-Retinal, EYE - General
An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

What's trending Jun/Jul 2025

2 June 2025 | | EYE - Orbit, EYE - Vitreo-Retinal
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Inspiration #FlyingEyeHospital It was with great sadness that I read about the passing of Dr David Paton at the age of...

AOP welcomes focus on improved patient outcomes in Pharmacy Supervision Review Group report

21 August 2023 | AOP, pharmacy review, PSRG
Recommendations review legislative framework for the future delivery of pharmacy.

CHEC Northampton recognised as ‘Outstanding’

4 October 2023 | CHEC, industry, CQC, Jose Bailey
Care and Quality Commission awards community eye hospital highest possible rating.

Coventry Community Eye Hospital recognised as ‘Outstanding’

5 January 2024 | CHEC, community services, ophthalmology, hospital, rating, UK, Coventry
Care and Quality Commission awards CHEC highest possible rating.

Study calls for thorough investigation of patients with early signs of retinal vascular disease

2 February 2024 | Paracentral acute middle maculopathy, PAMM, moorfields, research, oculomics
Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk of heart attacks and strokes may be greater than previously shown, suggests a new study led by researchers at Moorfields Eye Hospital NHS Foundation Trust.

Jury for Fifth Annual Vesalius Innovation Award Announced; Karger Publishers and BMJ Group  Co-presenting

11 September 2024 | award, ceremonies, competition, publishing, education, BMJ, Karger
The Vesalius Innovation Award, recognising excellence in science communication, has announced its jury members. This year marks a first in the award’s five-year history, as BMJ Group joins Karger Publishers to co-present the award. The Vesalius Innovation Award for innovation...

Greater Manchester residents asked to share views on eyecare services

11 June 2025 | news, UK, patient stories, survey, eyecare services
NHS Greater Manchester is calling on residents to share their experiences of using eye care (ophthalmology) services as part of a region-wide evaluation aimed at improving care for people with eye disorders. This eight-week listening exercise, running from today, Monday,...

The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE

14 August 2025 | Leber’s hereditary optic neuropathy, idebenone, Pharmacology, new therapies, research
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....